Women presenting with vaginal infections with overlapping symptoms such as abnormal discharge, itching, or irritation are frequently treated based on nonspecific signs, visual assessment, or wet mount ...
SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular ...
Last week, the United States FDA granted Cepheid, a molecular diagnostic testing company, marketing authorization for the Xpert HCV test and the GeneXpert Xpress system. Xpert HCV is a molecular test ...
SUNNYVALE, Calif., July 7, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics, today announced the publication of a study demonstrating the real-world impact of the ...